Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Precipio, Inc. (PRPO)

Precipio Q2 revenue rises 22% to $7.0 million; adjusted EBITDA turns positive

Mixed Impact 3 of 5 earnings Written later

Precipio reported second-quarter 2026 revenue of $7.0 million, up from $6.7 million in the first quarter and 22% above the $5.7 million in the year-earlier quarter. Adjusted EBITDA, a non-GAAP measure, was $0.4 million, compared with a $(0.2) million loss in the first quarter, but the company's GAAP net result was a loss of $(0.2) million versus net income of $0.1 million a year earlier.

Key points

  • Q2 2026 revenue was $7.0 million, including $6.1 million in pathology revenue and $0.9 million in product revenue.
  • Adjusted EBITDA was $0.4 million in Q2 2026, versus $(0.2) million in Q1 2026.
  • GAAP net loss was $(0.2) million in Q2 2026, compared with net income of $0.1 million in Q2 2025.
  • Cash was over $3 million at quarter end, versus $1.1 million in Q2 2025, with $0.7 million generated from operations in the quarter.

The filing

CompanyPrecipio, Inc. (PRPO)
Form8-K, current report
Filed with the SECAug 14, 2026, 5:30 PM ET
Accession number0001104659-26-097364

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.